RESEARCHERS from Dundalk Institute of Technology (DkIT) have joined a PhD programme, which uses cutting-edge technologies to diagnose and treat diseases.
DkIT is participating with five other higher education institutions in a doctoral training programme developing new technologies, diagnostics and therapeutics for patients with a range of diseases.
The PhD Scholars’ Programme in BioAnalysis & Therapeutics (BioAT) will see DkIT partner with Dublin City University (DCU); Royal College of Surgeons in Ireland (RCSI); NUI Maynooth, Institute of Technology Tallaght and Athlone Institute of Technology.
DkIT’s involvement in the structured PhD programme will primarily involve researchers from the Institute’s internationally renowned Smooth Muscle Research Centre.
The programme will allow eligible graduates in the biomedical, chemical, physical or engineering sciences to apply for a four-year PhD programme during which they will be able to take relevant taught modules across the six higher education institutions.
The research opportunities that are available in the programme include cardiovascular disease; infection and inflammatory disease; neurological disease; cancer; regenerative medicine; metabolic disease; diagnostics; bio-photonics and imaging; medicinal chemistry; nano-bioanalytics; biosensors and biomedical devices.
DkIT Head of Research Dr Tim Mc Cormac said: “The programme also underlines the postgraduate opportunities that are increasingly available at Dundalk as we build our presence at fourth level in line with the drive towards the northeast being central to the ‘Smart Economy’.”
Participants will see their research applied in ‘real world’ contexts.